Newronika

Newronika

Restores brain and body functions with neural devices based on biosignal decoding.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
investor investor investor investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor investor investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
*

€13.6m

Series B
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR2017201820192020202120222023
Revenues0000000000000000000000000000
% growth(18 %)26 %(5 %)(3 %)(33 %)20 %11 %
EBITDA0000000000000000000000000000
% EBITDA margin(40 %)6 %(145 %)(484 %)(975 %)--
Profit0000000000000000000000000000
% profit margin4 %67 %(198 %)(446 %)(1036 %)--
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000

Source: Company filings or news article, Dealroom estimates

More about Newronika
Edit

Developer of a neuro-modulation device designed to restore brain and body functioning. The company's therapeutic device uses the retro-activity system to record brain activity and modulate neuro-stimulation to collect, analyze and interpret bio-signals, enabling patients to receive the right stimulation at the right moment to perform normal daily activities and improve their quality of life.

Keywords: Healthcare Devices, Services, Supplies, Brain Devices, Deep Brain Stimulation, Mental Fitness, Neuro Therapy, Neuromodulation Therapy, Therapeutic Instruments.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo